Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.79 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 1/20 | 0.79 |
| ▸ | HTR2A | P28223 | 1/20 | 0.79 |
| ▸ | HRH1 | P35367 | 1/20 | 0.79 |
| ▸ | SCN1A | P35498 | 1/20 | 0.79 |
| ▸ | SCN4A | P35499 | 1/20 | 0.79 |
| ▸ | BLM | P54132 | 1/20 | 0.79 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.79 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.79 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.79 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.79 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.79 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.79 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.79 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.70 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4560126 | 1.00 | CYP2C9 (0.79) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| SCHEMBL10521481 | 0.93 | CYP2C9 (0.64) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL5499612 | 0.89 | CYP2C9 (1.00) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL3440 | 0.89 | CYP2C9 (1.00) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL28905600 | 0.87 | CYP2C9 (0.88) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL2140317 | 0.87 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL5160618 | 0.87 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL157671 | 0.87 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL2905857 | 0.87 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL1461588 | 0.87 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114488123-B | Radar data and camera data fusion method and system | 超级视线科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-116630379-A | Stacked workpiece shielding point cloud registration method and device based on grid feature description | 浙江工业大学 | 2023-08-22 | — | — | CN | claimed |
| CN-115760945-A | Method and system for acquiring stable target detection frame based on target detection | 智慧互通科技股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-114488123-A | Radar data and camera data fusion method and system | 超级视线科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20260060969-A1 | METHODS FOR THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS | INST NAT SANTE RECH MED (FR) | 2026-03-05 | — | — | US | disclosed |
| US-12565505-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260000658-A1 | METHODS FOR THE TREATMENT OF PROLIFERATIVE GLOMERULONEPHRITIS | INST NAT SANTE RECH MED (FR) | 2026-01-01 | — | — | US | disclosed |
| US-20250346693-A1 | HIGH-PERFORMANCE ZIEGLER CATALYST FOR LOOP-SLURRY PROCESS | EQUISTAR CHEMICALS, LP (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250244751-A1 | SMART LOADING OPTIMIZER ENGINE (SLOPE) USING ARTIFICIAL INTELLIGENCE | SAUDI ARABIAN OIL COMPANY (SA) | 2025-07-31 | — | — | US | disclosed |
| US-20250223297-A1 | NOVEL RAPAMYCIN DERIVATIVES | NOVARTIS AG (CH) | 2025-07-10 | — | — | US | disclosed |
| EP-4565217-A1 | METHODS FOR THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-06-11 | — | — | EP | disclosed |
| CN-119954829-A | MTORC1 modulators and uses thereof | 艾奥维安制药公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2008061781-A1 | THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES | NV REMYND (BE) | 2008-05-29 | — | — | WO | disclosed |
| EP-1860434-A1 | Method for analysing substance mixtures | Shimadzu Europa GmbH (DE) | 2007-11-28 | — | — | EP | disclosed |
| EP-0893453-B1 | Chiral separation of pharmaceutical compounds with charged cyclodextrins using capillary electrophoresis | BECKMAN COULTER INC (US) | 2004-04-07 | — | — | EP | disclosed |
| US-6316613-B1 | USED TO SEPARATE OPTICAL ISOMERS | BECKMAN COULTER, INC. | 2001-11-13 | — | — | US | disclosed |
| EP-0893453-A2 | Chiral separation of pharmaceutical compounds with charged cyclodextrins using capillary electrophoresis | Beckman Coulter, Inc. (US) | 1999-01-27 | — | — | EP | disclosed |
| US-5098576-A | Nonporous silicon carbide as adsorbants for liquid chromatography | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-03-24 | — | — | US | disclosed |
| EP-0368138-A1 | Adsorbent for chromatography | MERCK PATENT GmbH (DE) | 1990-05-16 | — | — | EP | disclosed |
| US-4006232-A | Therapeutic method of treating cardiac arrhythmias utilizing 3-substituted diphenylhydantoins | MILES LABORATORIES, INC. (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565505-B2 | mTORC modulators and uses thereof | RICTOR, MTOR, RPTOR | CYP2C9 3342/4885CACNA1F 1963/4885ALDH1A1 4613/4885 |
| US-20260000658-A1 | METHODS FOR THE TREATMENT OF PROLIFERATIVE GLOMERULONEPHRITIS | PIK3R4, PIK3CA, PIK3R5 | CYP2C9 3713/4885CACNA1F 4252/4885ALDH1A1 4742/4885 |
| US-20250223297-A1 | NOVEL RAPAMYCIN DERIVATIVES | MTOR, RICTOR, RPTOR | CYP2C9 3285/4885CACNA1F 3735/4885ALDH1A1 4143/4885 |
| US-20260060969-A1 | METHODS FOR THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS | PIK3R4, PIK3R5, PIK3R1 | CYP2C9 3039/4885CACNA1F 2723/4885ALDH1A1 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.